The FDA has granted expanded use and new indications for products manufactured by MRK.
1 report, 1 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has granted expanded use and new indications for products manufactured by MRK.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- The FDA recommended advancement for a new drug application submitted by a company.
- GSK is submitting data to the FDA regarding potential expansion of its drug indications.
- The FDA granted clearance for a Genotek kit, which is used in conjunction with Hoffmann-La Roche molecular testing.
- Collaboration revenue from GSK increased total revenue, and FDA action is needed for tepipenem HBR approval.
- A product was launched in the U.S. market following FDA involvement.